WuXi Biologics WuXi AppTec is expected to provide world-class integrated biopharmace
WuXi Biologics is a subsidiary of the WuXi AppTec Group with branches in Wuxi, Shanghai and Suzhou. As a platform for innovative companies to realize their dream of developing new drugs, WuXi AppTec is expected to provide world-class integrated biopharmaceutical R&D and manufacturing services to more innovative biotech companies at home and abroad in the future, accelerating the process of bringing innovative biopharmaceuticals to market in China for the benefit of patients.
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
ResearchConsumer Staples, Technology, Healthcare
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Consumer Discretionary, Consumer Staples
Tech for Global, Globalization Footprints of the Established and the New
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM